What is Dianthus Therapeutics's net income?

Dianthus Therapeutics (DNTH) reported net income of -$40.83M in Q1 2026.

How has Dianthus Therapeutics's net income changed year-over-year?

Dianthus Therapeutics's net income decreased by 38.4% year-over-year, from -$29.51M to -$40.83M.

What is the long-term trend for Dianthus Therapeutics's net income?

Over 3 years (2021 to 2024), Dianthus Therapeutics's net income has grown at a 6.1% compound annual growth rate (CAGR), from -$71.14M to -$84.97M.

What does net income mean?

Net income as the starting point for the indirect method operating cash flow reconciliation.

Dianthus Therapeutics DNTH Net Income

Net Income at other companies

Johnson & JohnsonJNJ

$5.24B-52.4%

AmgenAMGN

$1.82B+5.1%

Spyre Therapeutics, Inc.SYRE

-$69.01M-54.1%

Kymera TherapeuticsKYMR

-$69.23M-5.6%

Protagonist TherapeuticsPTGX

$3.78M+132%

TG TherapeuticsTGTX

$19.78M+291%

Other financials

Income statement

See full

Revenue$396.0K-81.8%

Operating income-$46.5M-40.3%

Net income-$40.8M-38.4%

EPS (diluted)-$0.85-3.7%

Balance sheet

See full

Cash & equivalents$627.7M+6,105%

Total debt$1.4M-2.3%

Total equity$1.2B+266%

Total assets$1.2B+258%

Cash flow

See full

Operating cash flow-$28.9M-4.4%

CapEx$10.0K-58.3%

Free cash flow-$28.9M-4.4%

Valuation

See full

Market cap$4.51B+662%

Profitability

See full

Operating margin-4,558.4%-9,354pp

Net margin-4,104.8%-7,304pp

FCF margin-3,561.6%-6,956pp

Returns & leverage

See full

Return on equity-28.6%+3.2pp

Debt / equity0×0.0×

Current ratio29.3×+13.3×

Where this comes from

Reported directly by Dianthus Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ProfitLoss.

The official record: Dianthus Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dianthus Therapeutics's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Dianthus Therapeutics's net income?: Dianthus Therapeutics (DNTH) reported net income of -$40.83M in Q1 2026.
How has Dianthus Therapeutics's net income changed year-over-year?: Dianthus Therapeutics's net income decreased by 38.4% year-over-year, from -$29.51M to -$40.83M.
What is the long-term trend for Dianthus Therapeutics's net income?: Over 3 years (2021 to 2024), Dianthus Therapeutics's net income has grown at a 6.1% compound annual growth rate (CAGR), from -$71.14M to -$84.97M.
What does net income mean?: Net income as the starting point for the indirect method operating cash flow reconciliation.